Zobrazeno 1 - 10
of 94
pro vyhledávání: '"W. Nicol Keith"'
Autor:
Alan E. Bilsland, Yu Liu, Andrew Turnbull, David Sumpton, Katrina Stevenson, Claire J. Cairney, Susan M. Boyd, Jon Roffey, David Jenkinson, W. Nicol Keith
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 9, Pp 893-907 (2019)
Telomere signaling and metabolic dysfunction are hallmarks of cell aging. New agents targeting these processes might provide therapeutic opportunities, including chemoprevention strategies against cancer predisposition. We report identification and c
Externí odkaz:
https://doaj.org/article/936206170ac349faab43d8b1ddaedfcd
Autor:
Alan E. Bilsland, Angelo Pugliese, Yu Liu, John Revie, Sharon Burns, Carol McCormick, Claire J. Cairney, Justin Bower, Martin Drysdale, Masashi Narita, Mahito Sadaie, W. Nicol Keith
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 17, Iss 9, Pp 704-715 (2015)
Cellular senescence is a barrier to tumorigenesis in normal cells, and tumor cells undergo senescence responses to genotoxic stimuli, which is a potential target phenotype for cancer therapy. However, in this setting, mixed-mode responses are common
Externí odkaz:
https://doaj.org/article/f63495499283424f8b4feb22d3460e78
Autor:
Sofie Degerman, Mattias Landfors, Jan Konrad Siwicki, John Revie, Magnus Borssén, Emma Evelönn, Erik Forestier, Krystyna H. Chrzanowska, Patrik Rydén, W. Nicol Keith, Göran Roos
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 16, Iss 7, Pp 606-615 (2014)
We have previously described gene expression changes during spontaneous immortalization of T-cells, thereby identifying cellular processes important for cell growth crisis escape and unlimited proliferation. Here, we analyze the same model to investi
Externí odkaz:
https://doaj.org/article/45a9461da5ed43f1b09b8e7969e6aabe
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 7, Iss 11, Pp 1020-1029 (2005)
Telomerase expression represents a good target for cancer gene therapy. The promoters of the core telomerase catalytic [human telomerase reverse transcriptase (hTERT)] and RNA [human telomerase RNA (hTR)] subunits show selective activity in cancer ce
Externí odkaz:
https://doaj.org/article/c08d137303514853a723ca27f3e65ce6
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 7, Iss 6, Pp 614-622 (2005)
Telomerase plays a role in the unlimited replicative capacity of the majority of cancer cells and provides a potential anticancer target. The regulation of telomerase is complex but transcriptional control of its two essential components, hTERC (RNA
Externí odkaz:
https://doaj.org/article/3dde767e5f9a46b198f16621462b083d
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 2, Iss 3, Pp 197-201 (2000)
Telomerase, the enzyme that maintains the ends of chromosomes, is absent from the majority of somatic cells but is present and active in most tumours. The gene for the reverse transcriptase component of telomerase (hTERT) has recently been identified
Externí odkaz:
https://doaj.org/article/437540c1342040fb8c2a32ef0689d029
Autor:
Jiang-Qin Zhao, Rosalind M. Glasspool, Stacey F. Hoare, Alan Bilsland, Istvan Szatmari, W. Nicol Keith
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 2, Iss 6, Pp 531-539 (2000)
Expression of the human telomerase RNA component gene, hTERC is essential for telomerase activity. The hTERC gene is expressed during embryogenesis and then downregulated during normal development, leaving most adult somatic cells devoid of hTERC exp
Externí odkaz:
https://doaj.org/article/82c78de49e87417faf770f10ea51b8ad
Autor:
Karin A. Oien, W. Nicol Keith, Christopher Bellamy, Caroline Verbeke, Jacqueline Mooney, Ian Downie, Alexandra K. Bell, Jan Komorowski, Ernst C. Wit, Torgeir R. Hvidsten, Jayne L. Dennis
Purpose: Patients with metastatic adenocarcinoma of unknown origin are a common clinical problem. Knowledge of the primary site is important for their management, but histologically, such tumors appear similar. Better diagnostic markers are needed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06c64dd357e19c88804d6b69181e4539
https://doi.org/10.1158/1078-0432.c.6518334
https://doi.org/10.1158/1078-0432.c.6518334
Autor:
Karin A. Oien, W. Nicol Keith, Christopher Bellamy, Caroline Verbeke, Jacqueline Mooney, Ian Downie, Alexandra K. Bell, Jan Komorowski, Ernst C. Wit, Torgeir R. Hvidsten, Jayne L. Dennis
Supplementary Figure 1 from Markers of Adenocarcinoma Characteristic of the Site of Origin: Development of a Diagnostic Algorithm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1de19d5d79aa75d79f4c437fc0d672b
https://doi.org/10.1158/1078-0432.22441206
https://doi.org/10.1158/1078-0432.22441206
Autor:
Karin A. Oien, W. Nicol Keith, Christopher Bellamy, Caroline Verbeke, Jacqueline Mooney, Ian Downie, Alexandra K. Bell, Jan Komorowski, Ernst C. Wit, Torgeir R. Hvidsten, Jayne L. Dennis
Supplementary Table 1 from Markers of Adenocarcinoma Characteristic of the Site of Origin: Development of a Diagnostic Algorithm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3890fda40d3f774ca25a1961dca10b4b
https://doi.org/10.1158/1078-0432.22441203
https://doi.org/10.1158/1078-0432.22441203